Search

everythinglearnresearchcommunity

for

Search:↓

Angelica gigas Nakai root extracts may help with cancer, pain, memory loss, and metabolic issues.

Scopolin and scopoletin from Merremia peltata leaves may help treat hair loss and showed promising results in rabbit tests.

Moxibustion may help improve ovarian function by changing androgen levels.

The chapter explains the causes of excessive hair growth and masculinization in women and how to measure hormone levels related to these conditions.

The document concludes that sex hormones are crucial for mammalian reproduction, health, and behavior, and require more research for therapeutic use.

Female pattern hair loss involves thinning hair on crown and frontal scalp, diagnosed by hair ratio, and treated with minoxidil, antiandrogens, or hair transplantation.

Flutamide and a new synthetic steroid affected brain and prostate chemicals and showed potential for treating androgen-related conditions and epilepsy.

New oral treatment, finasteride, effectively and safely treats common hair loss.

A new method accurately measures DHEAS in blood, improving on current tests.

Hydroxychloroquine may help treat benign prostatic hyperplasia by reducing inflammation and promoting cell death.

PCOS is managed with medication, lifestyle changes, and a healthy diet.

AGA, a common hair loss, is caused by genetics, hormones, age, and environmental factors.

Plant extracts like Avicennia marina, Boehmeria nipononivea, and Camellia sinensis could potentially treat hair loss with fewer side effects than synthetic drugs.

Citrullus colocynthis and Citrullus lanatus have potential health benefits but may also cause reproductive toxicity.

Hair loss in Androgenetic alopecia (AGA) is due to altered cell sensitivity to hormones, not increased hormone levels. Hair growth periods shorten over time, causing hair to become thinner and shorter. This is linked to miscommunication between cell pathways in hair follicles. There's also a change in gene expression related to blood vessels and cell growth in balding hair follicles. The exact molecular causes of AGA are still unclear.

Women with PCOS have altered brain structure and reduced cognitive performance.

Most 46XX CAH patients have female identity, but a few identify as male and may need treatment and surgery.

Testosterone therapy can improve sexual function in women but long-term safety is unclear.

Adult acne is more common in women, often linked to hormones, and can be harder to treat.

Testosterone, progesterone, and levonorgestrel change enzyme levels related to fat production in hamster skin, which could affect skin oil and acne.

Birth control pills with low-dose estrogen and antiandrogenic progestins can effectively treat acne.

Hormonal therapies are effective for managing hair and skin symptoms in women with PCOS.

Generalized glucocorticoid resistance causes hormone imbalances and varied symptoms due to gene mutations.

Hirsutism is mainly caused by high androgen levels or sensitivity, with PCOS being the most common cause.

Treating hirsutism and acne in women with PCOS needs a personalized approach using oral contraceptives, antiandrogens, and sometimes metformin.

Long-term use of 5α-reductase inhibitors may improve survival in men with kidney cancer.

PCOS-related infertility is managed with lifestyle changes and medications.

New treatments for hair loss show promise but need more testing for effectiveness and safety.

Genetics can help tailor treatments for male pattern hair loss, improving outcomes like stabilization or modest regrowth.

Skin symptoms often reveal hormonal imbalances in PCOS.